Anti-Flt-1 antibodies for treating Duchenne muscular dystrophy
US-12435146-B2 · Oct 7, 2025 · US
Shire Human Genetic Therapies holds 234 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 234 |
| Recent patents | 9 |
| First publication | Jan 1, 2015 |
| Latest publication | Oct 7, 2025 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12435146-B2 · Oct 7, 2025 · US
US-2025282808-A1 · Sep 11, 2025 · US
US-2025281482-A1 · Sep 11, 2025 · US
US-12350267-B2 · Jul 8, 2025 · US
US-12145959-B2 · Nov 19, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12435146-B2 · Oct 7, 2025 · US
US-2025282808-A1 · Sep 11, 2025 · US
US-2025281482-A1 · Sep 11, 2025 · US
US-12350267-B2 · Jul 8, 2025 · US
US-12145959-B2 · Nov 19, 2024 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P43/00 | 87 |
| A61K9/0019 | 82 |
| A61P3/00 | 72 |
| A61P25/00 | 64 |
| A61K38/47 | 59 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 213 |
| Human Necessities | 202 |
| Physics | 38 |
| Cross-Sectional Technologies | 8 |
| Operations & Transport | 7 |
| Electricity | 3 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.